Aspirin controls two key procedures to kill bowel cancers cells Aspirin kills malignancy cells by controlling two key processes that impact energy use in cells and could explain how aspirin may prevent bowel cancer tadalafil ohne rezept more info . The research is released in this month’s Gastroenterology. Cancer Analysis UK-funded scientists have discovered that aspirin switches off mTOR, a protein that’s overactive in bowel cancer cells. MTOR has a component in allowing cancer cells to produce unwanted proteins leading to them to grow quicker than they should. At the same time, aspirin activates another proteins, AMPK, which switches on pathways that generate energy but halts additional processes in the cell that require energy, including mTOR.